Opiant Pharmaceuticals to Report First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 10, 2022
May 03 2022 - 08:00AM
Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a
specialty pharmaceutical company developing medicines to treat
addictions and drug overdose, will report its financial results for
the first quarter ended March 31, 2022, after the financial markets
close on Tuesday, May 10, 2022.
The Company’s management team is scheduled to host a conference
call and webcast with slides at 4:30 p.m.
ET on Tuesday, May 10, 2022. To access the call, please
dial 1-877-407-0792 in the U.S. or 1-201-689-8263 outside
the U.S. and provide the conference ID number: 13728852.
To access the live webcast, please visit
https://viavid.webcasts.com/starthere.jsp?ei=1542632&tp_key=dabaa0a667.
Following the live webcast, an archived version of the call will be
available on the website.
Tuesday May 10 @ 4:30 pm ET
Domestic: |
1-877-407-0792 |
International: |
1-201-689-8263 |
Conference ID: |
13728852 |
Webcast: |
https://viavid.webcasts.com/starthere.jsp?ei=1542632&tp_key=dabaa0a667 |
About Opiant Pharmaceuticals,
Inc.Opiant Pharmaceuticals, Inc., the company that
developed NARCAN® Nasal Spray, is building a
leading franchise of new medicines to combat addictions
and drug overdose.For more information
visit: www.opiant.com.
For Media and Investor Inquiries:Ben Atkins,
Opiant(310) 598-5410batkins@opiant.com
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Feb 2024 to Mar 2024
Opiant Pharmaceuticals (NASDAQ:OPNT)
Historical Stock Chart
From Mar 2023 to Mar 2024